GIBSON INDEX NEWSLETTER - SEPTEMBER 2009

The market for endovascular stent grafts for the treatment of AAA is currently worth over $800 million and is expected to grow to around $1.6 billion by 2015. Aorfix is currently being commercialised in the EU, with a pivotal clinical trial ongoing in the USA. ................
................